PepGen Inc

PepGen is a clinical-stage biotechnology company developing oligonucleotide therapies for neuromuscular and neurological diseases using its Enhanced Delivery Oligonucleotide platform, which uses cell-penetrating peptides to improve oligonucleotide uptake and activity.